Is adalimumab protective in ischemia-reperfusion injury in lung?

OBJECTIVE(S): Increasing cytokines and reactive oxygen species (ROS) during ischemia reperfusion (I-R) leads to the lung damage. Adalimumab (Ada) is a potent tumor necrosis factor-alpha (TNF-α) inhibitor agent. We aimed to evaluate whether Ada would prevent the lung tissue from damage development ov...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurt, Aysel, Tumkaya, Levent, Kalkan, Yildiray, Turut, Hasan, Cure, Medine Cumhur, Cure, Erkan, Sehitoglu, Ibrahim, Bilgin, Hacer, Usta, Mustafa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mashhad University of Medical Sciences 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4764110/
https://www.ncbi.nlm.nih.gov/pubmed/26949496

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4764110/
https://www.ncbi.nlm.nih.gov/pubmed/26949496

Ejemplares similares